Acetylation-dependent regulation of PD-L1 nuclear translocation dictates the efficacy of anti-PD-1 immunotherapy

Journal: Nature Cell Biology

Published: 2020-08-24

DOI: 10.1038/s41556-020-0562-4

Affiliations: 14

Authors: 27

Go to article
Institutions Share
Department of Pathology, BIDMC, United States of America (USA) 0.35
Department of Cancer Biology, DFCI, United States of America (USA) 0.09
Harvard Department of Genetics, United States of America (USA) 0.09
Department of Molecular Genetics, TMDU, Japan 0.09
The First Affiliated Hospital of Xi'an Jiaotong University, XJTU, China 0.07
Department of Medical Oncology, DFCI, United States of America (USA) 0.07
Department of Oncology / McArdle Laboratory for Cancer Research, UW-Madison, United States of America (USA) 0.07
Department of Clinical Genomics, NCC, Japan 0.04
Department of Biostatistics and Computational Biology (BCB), DFCI, United States of America (USA) 0.04
Center for Mitchondrial Biology and Medicine (CMBM), XJTU, China 0.02
MOE Key Laboratory of Biomedical Information Engineering, XJTU, China 0.02
Harvard Department of Biomedical Informatics (DBMI), United States of America (USA) 0.02
Division of Genetics and Genomics, BCH, United States of America (USA) 0.02
Division of Pediatric Dentistry, Tohoku University, Japan 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER